Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 7, 2007 - Issue 9
Submit an article Journal homepage
83
Views
11
CrossRef citations to date
0
Altmetric
Clinical Trials Report

Safety and tolerability of sorafenib in clear-cell renal cell carcinoma: a Phase III overview

Thomas E Hutson Baylor University Medical Center, GU Oncology Program, Texas Oncology, PA, Sammons Cancer Center, 3535 Worth Street, Dallas TX 75246, USA. [email protected]
Pages 1193-1202 | Published online: 10 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Joanna Mangana, Mitchell P Levesque, Maria B Karpova & Reinhard Dummer. (2012) Sorafenib in melanoma. Expert Opinion on Investigational Drugs 21:4, pages 557-568.
Read now
Chih-Hsun Yang, Cheng-Keng Chuang, Jia-Juan Hsieh & John Wen-Cheng Chang. (2010) Targeted therapy and hand–foot skin reaction in advanced renal cell carcinoma. Expert Opinion on Drug Safety 9:3, pages 459-470.
Read now
Benoit Blanchet, Bertrand Billemont, Stéphane Barete, Hélène Garrigue, Laure Cabanes, Romain Coriat, Camille Francès, Bertrand Knebelmann & François Goldwasser. (2010) Toxicity of sorafenib: clinical and molecular aspects. Expert Opinion on Drug Safety 9:2, pages 275-287.
Read now

Articles from other publishers (8)

Luis León, Luis Miguel Antón-Aparicio, Emilio Esteban-González, Martin Lázaro-Quintela & Sergio Vázquez-Éstevez. 2015. Renal Cell Carcinoma. Renal Cell Carcinoma 377 416 .
J. J. Koldenhof, P. O. Witteveen, R. de Vos, M. Walraven, C. N. Tillier, H. M. W. Verheul & S. C. C. M. Teunissen. (2014) Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions. Supportive Care in Cancer.
Crossref
Daniel R Greenwald, Hailun Li, Selina M Luger, Ronald S Go, David King, Taral Patel, Randy D Gascoyne, Jill Kolesar, Brad S Kahl & Sandra Horning. (2013) A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404). Journal of Hematology & Oncology 6:1.
Crossref
E. Barrascout, J. Medioni, F. Scotte, J. Ayllon, A. Mejean, C.A. Cuenod, Eric Tartour, R. Elaidi & S. Oudard. (2010) Inhibiteurs de l’angiogenèse : revues de l’apport thérapeutique du sorafenib, du sunitinib et du bevacizumab dans le cancer du rein métastatique. Bulletin du Cancer 97:2, pages S29-S43.
Crossref
V. Echeverria, S. Burgess, J. Gamble-George, R. Zeitlin, X. Lin, C. Cao & G.W. Arendash. (2009) Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience 162:4, pages 1220-1231.
Crossref
John Farley & Michael J. Birrer. 2010. Ovarian Cancer. Ovarian Cancer 63 84 .
Thomas E. Hutson, Robert A. Figlin, John G. Kuhn & Robert J. Motzer. (2008) Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies. The Oncologist 13:10, pages 1084-1096.
Crossref
Valentina Echeverria, Sarah Burgess, Joyonna Gamble-George, Gary W. Arendash & Bruce A. Citron. (2008) Raf inhibition protects cortical cells against β-amyloid toxicity. Neuroscience Letters 444:1, pages 92-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.